keyword
https://read.qxmd.com/read/38687009/computed-tomographic-features-of-canine-prostatic-carcinoma
#21
JOURNAL ARTICLE
Pascal Urlings, Irina Gramer, Coleen Jones, Helen Dirrig
Canine prostatic carcinoma (PC) has incompletely defined CT features. The purpose of this multicenter retrospective case series was to assess prostatic, regional, and distant findings of PC. Thirty dogs were enrolled. Consistent prostatic features included postcontrast heterogeneity with hypoattenuating, nonenhancing areas (30/30), capsular distortion (29/30), prostatic urethral effacement, displacement, or invasion (28/30), precontrast heterogeneity (27/30), and mineralization (24/30) which was always within or at the margin of the hypoattenuating areas...
April 30, 2024: Veterinary Radiology & Ultrasound
https://read.qxmd.com/read/38686071/lethal-disseminated-intravascular-coagulation-induced-by-primary-and-metastatic-neuroendocrine-prostate-cancer
#22
Takashi Ando, Taro Sasaki, Makoto Naito
INTRODUCTION: Neuroendocrine prostate cancer has a poor prognosis. Although disseminated intravascular coagulation associated with malignancy can be lethal, it very rarely occurs among patients with primary neuroendocrine prostate cancer. CASE PRESENTATION: An 80-year-old man presented to our hospital with bloody sputum. Blood examination indicated disseminated intravascular coagulation. Serum levels of prostate-specific antigen and neuron-specific enolase were 44...
May 2024: IJU case reports
https://read.qxmd.com/read/38679995/antiproliferative-and-apoptotic-effects-of-murici-byrsonima-crassifolia-l-kunth-and-verbascifolia-l-dc-and-tapereb%C3%A3-spondias-mombin-l-extracts-in-human-prostate-cell-line-pc-3
#23
JOURNAL ARTICLE
Thuane Oliveira Do Amaral Muxfeldt Paim, Nayara Frauches Simas, Joel Pimentel Abreu, Lana Rosa, Thuane Passos Barbosa Lima, Anderson Junger Teodoro
OBJECTIVE: The present study aimed to evaluate the antiproliferative and apoptotic effects of extracts obtained from the murici (Byrsonima crassifolia (L.) Kunth and verbascifolia (L.) DC) and taperebá (Spondias mombin L.) pulps, on cell proliferation, cell cycle and apoptosis on human prostate cell line (PC-3). METHODS: Four extract was produced from the pulps:  murici aqueous extract (MA), taperebá aqueous extract (TA), murici ethanolic extract (ME) and taperebá ethanolic extract (TE)...
April 1, 2024: Asian Pacific Journal of Cancer Prevention: APJCP
https://read.qxmd.com/read/38676768/identification-of-potential-targetable-genes-in-papillary-follicular-and-anaplastic-thyroid-carcinoma-using-bioinformatics-analysis
#24
JOURNAL ARTICLE
Shipra Agarwal, Shikha Gupta, Rishav Raj
PURPOSE: To perform an extensive exploratory analysis to build a deeper insight into clinically relevant molecular biomarkers in Papillary, Follicular, and Anaplastic thyroid carcinomas (PTC, FTC, ATC). METHODS: Thirteen Thyroid Cancer (THCA) datasets incorporating PTC, FTC, and ATC were derived from the Gene Expression Omnibus. Genes differentially expressed (DEGs) between THCA and normal were identified and subjected to GO and KEGG analyses. Multiple topological properties were harnessed and protein-protein interaction (PPI) networks were constructed to identify the hub genes followed by survival analysis and validation...
April 27, 2024: Endocrine
https://read.qxmd.com/read/38674331/comprehensive-analysis-of-clinically-relevant-copy-number-alterations-cnas-using-a-523-gene-next-generation-sequencing-panel-and-nxclinical-software-in-solid-tumors
#25
JOURNAL ARTICLE
Vivek Gupta, Vishakha Vashisht, Ashutosh Vashisht, Ashis K Mondal, Ahmet Alptekin, Harmanpreet Singh, Ravindra Kolhe
Copy number alterations (CNAs) are significant in tumor initiation and progression. Identifying these aberrations is crucial for targeted therapies and personalized cancer diagnostics. Next-generation sequencing (NGS) methods present advantages in scalability and cost-effectiveness, surpassing limitations associated with reference assemblies and probe capacities in traditional laboratory approaches. This retrospective study evaluated CNAs in 50 FFPE tumor samples (breast cancer, ovarian carcinoma, pancreatic cancer, melanoma, and prostate carcinoma) using Illumina's TruSight Oncology 500 (TSO500) and the Affymetrix Oncoscan Molecular Inversion Probe (OS-MIP) (ThermoFisher Scientific, Waltham, MA, USA)...
March 23, 2024: Genes
https://read.qxmd.com/read/38668436/canine-prostate-cancer-current-treatments-and-the-role-of-interventional-oncology
#26
REVIEW
Erin A Gibson, William T N Culp
Prostate carcinoma is one of the most common cancers worldwide in men, with over 3 million men currently living with prostate carcinoma. In men, routine screening and successful treatment schemes, including radiation, prostatectomy, or hormone therapy, have allowed for high survivability. Dogs are recognized as one of the only mammals to spontaneously develop prostate neoplasia and are an important translational model. Within veterinary medicine, treatment options have historically been limited in efficacy or paired with high morbidity...
April 9, 2024: Veterinary Sciences
https://read.qxmd.com/read/38668075/antibody-drug-conjugates-in-the-treatment-of-genitourinary-cancers-an-updated-review-of-data
#27
REVIEW
Prathana Nathan, Adnan Rajeh, Meh Noor, Gabriel Boldt, Ricardo Fernandes
The treatment landscape of genitourinary cancers has significantly evolved over the past few years. Renal cell carcinoma, bladder cancer, and prostate cancer are the most common genitourinary malignancies. Recent advancements have produced new targeted therapies, particularly antibody-drug conjugates (ADCs), due to a better understanding of the underlying oncogenic factors and molecular mechanisms involved. ADCs function as a 'drug delivery into the tumor' system. They are composed of an antigen-directed antibody linked to a cytotoxic drug that releases cytotoxic components after binding to the tumor cell's surface antigen...
April 19, 2024: Current Oncology
https://read.qxmd.com/read/38667771/assessment-of-silver-nanoparticles-derived-from-brown-algae-sargassum-vulgare-insight-into-antioxidants-anticancer-antibacterial-and-hepatoprotective-effect
#28
JOURNAL ARTICLE
Ragaa A Hamouda, Ebtehail S Aljohani
Algae are used as safe materials to fabricate novel nanoparticles to treat some diseases. Marine brown alga Sargassum vulgare are used to fabricate silver nanoparticles (Sv/Ag-NPs). The characterization of Sv/Ag-NPs was determined by TEM, EDX, Zeta potential, XRD, and UV spectroscopy. The Sv/Ag-NPs were investigated as antioxidant, anticancer, and antibacterial activities against Gram-positive bacteria Bacillus mojavensis PP400982, Staphylococcus caprae PP401704, Staphylococcus capitis PP402689, and Staphylococcus epidermidis PP403851...
March 28, 2024: Marine Drugs
https://read.qxmd.com/read/38666920/parp-targeted-radiotheranostics-with-auger-electrons-an-updated-overview
#29
REVIEW
Luca Filippi, Luca Urso, Laura Evangelista
Auger electrons (AEs) represent an intriguing topic in the field of radionuclide therapy. They are emitted by several radionuclides commonly used in nuclear medicine (indium-111, iodine-123, iodine-125), allowing for highly localized energy deposition and thus exerting a radiotoxic effect on specific cellular and sub-cellular targets. However, due to their short range in matter, AEs have had limited use in therapeutic applications so far. In recent years, the synthesis of various radiopharmaceuticals capable of binding to the enzyme poly(ADP-ribose) polymerase 1 has reignited interest in this type of therapy, laying the groundwork for a theranostic approach based on radionuclides emitting AEs...
March 31, 2024: Current Issues in Molecular Biology
https://read.qxmd.com/read/38663894/clear-cell-renal-cell-carcinoma-with-high-psma-uptake
#30
JOURNAL ARTICLE
Maria Monica Yepes, Andrés Felipe Herrera Ortiz, Valeria Del Castillo, Julian Rojas
No abstract text is available yet for this article.
April 24, 2024: BMJ Case Reports
https://read.qxmd.com/read/38660302/khdrbs1-as-a-novel-prognostic-signaling-biomarker-influencing-hepatocellular-carcinoma-cell-proliferation-migration-immune-microenvironment-and-drug-sensitivity
#31
JOURNAL ARTICLE
Rui Fan, Fahui Liu, Qiming Gong, Donghua Liu, Shihang Tang, Dongyan Shen
BACKGROUND: Human tumors pose significant challenges, with targeted therapy against specific molecular targets or signaling pathways being a mainstay alongside surgical resection. Previous studies have implicated KHDRBS1 in the oncogenesis of certain human tumors such as colorectal and prostate cancers, underscoring its potential as a therapeutic target. However, the comprehensive expression pattern of KHDRBS1 in hepatocellular carcinoma (HCC) warrants further exploration. METHODS: Integrating and analyzing multi-omics, multi-cohort data from public databases, coupled with clinical samples and molecular biology validation, we elucidate the oncogenic role of KHDRBS1 in HCC progression...
2024: Frontiers in Immunology
https://read.qxmd.com/read/38659592/discovery-of-a-novel-natural-compound-vitekwangin-b-with-ano1-protein-reduction-properties-and-anticancer-potential
#32
JOURNAL ARTICLE
Yohan Seo, Sion Lee, Minuk Kim, Dongguk Kim, Sung Baek Jeong, Raju Das, Armin Sultana, SeonJu Park, Nguyen Xuan Nhiem, Phan Thi Thanh Huong, Oh-Bin Kwon, Wan Namkung, Joohan Woo
Background: Prostate cancer and non-small cell lung cancer (NSCLC) present significant challenges in the development of effective therapeutic strategies. Hormone therapies for prostate cancer target androgen receptors and prostate-specific antigen markers. However, treatment options for prostatic small-cell neuroendocrine carcinoma are limited. NSCLC, on the other hand, is primarily treated with epidermal growth factor receptor (EGFR) tyrosine kinase inhibitors but exhibits resistance. This study explored a novel therapeutic approach by investigating the potential anticancer properties of vitekwangin B, a natural compound derived from Vitex trifolia ...
2024: Frontiers in Pharmacology
https://read.qxmd.com/read/38659202/effective-detection-of-braf-v595e-mutation-in-canine-urothelial-and-prostate-carcinomas-using-immunohistochemistry
#33
JOURNAL ARTICLE
Leonore Aeschlimann, Alexandra Kehl, Franco Guscetti, Caroline Posthaus, Heike Aupperle-Lellbach, Sven Rottenberg, Simone de Brot
Canine urothelial carcinoma (UC) and prostate carcinoma (PC) frequently exhibit the BRAFV595E mutation, akin to the BRAFV600E mutation common in various human cancers. Since the initial discovery of the BRAF mutation in canine cancers in 2015, PCR has been the standard method for its detection in both liquid and tissue biopsies. Considering the similarity between the canine BRAFV595E and human BRAFV600E mutations, we hypothesized that immunohistochemistry (IHC) using a BRAFV600E -specific antibody could effectively identify the canine mutant BRAFV595E protein...
April 24, 2024: Veterinary and Comparative Oncology
https://read.qxmd.com/read/38650632/activation-of-p53-signaling-and-regression-of-breast-and-prostate-carcinoma-cells-by-spirooxindole-benzimidazole-small-molecules
#34
JOURNAL ARTICLE
Assem Barakat, Saeed Alshahrani, Abdullah Mohammed Al-Majid, Abdullah Saleh Alamary, Matti Haukka, Marwa M Abu-Serie, Alexander Dömling, Luis R Domingo, Yaseen A M M Elshaier
This study discusses the synthesis and use of a new library of spirooxindole-benzimidazole compounds as inhibitors of the signal transducer and activator of p53, a protein involved in regulating cell growth and cancer prevention. The text includes the scientific details of the [3 + 2] cycloaddition (32CA) reaction between azomethine ylide 7a and ethylene 3a within the framework of Molecular Electron Density Theory. The mechanism of the 32CA reaction proceeds through a two-stage one-step process, with emphasis on the highly asynchronous transition state structure...
2024: Frontiers in Pharmacology
https://read.qxmd.com/read/38646206/pseudosarcomatous-fibromyxoid-tumor-of-the-prostate-a-rare-benign-lesion-mimicking-malignancy
#35
Kavita Somani, Pretty Singh
Psuedosarcomatous fibromyxoid tumor (PSFT) is an uncommon, non-malignant yet locally aggressive pseudotumor found in the genitourinary system. Despite being a benign spindle cell tumor without any documented cases of metastasis, its local aggressiveness can pose a life-threatening risk. The lack of specific clinical symptoms and the infiltrative characteristics of the lesion may lead to misdiagnosis as sarcomatoid carcinoma or sarcoma. Therefore, it is crucial to distinguish PSFT histologically and through immunohistochemistry from other spindle cell tumors to avoid unnecessary investigations and treatments...
March 2024: Curēus
https://read.qxmd.com/read/38642184/hbo-regulates-the-warburg-effect-of-hypoxic-hcc-cells-through-mir-103a-3p-trim35
#36
JOURNAL ARTICLE
Yuting Ding, Wenkang Luan, Zhe Wang, Bo Xie, Chengfa Sun
BACKGROUND: There are a lot of studies on the treatment of tumors with hyperbaric oxygen, while most of them are in breast cancer, prostate cancer and so on. However, there are still few studies on hyperbaric oxygen in treating hepatocellular carcinoma (HCC). According to the current data, hyperbaric oxygen is an effective means to intervene in tumors. The Warburg effect is a unique marker of glucose metabolism in tumors related to hypoxia, making it possible for hyperbaric oxygen to interfere with the tumor through the Warburg effect...
April 20, 2024: Discover. Oncology
https://read.qxmd.com/read/38641444/patient-characteristics-treatment-patterns-and-outcomes-for-patients-with-renal-cell-carcinoma-in-england-a-retrospective-cohort-study
#37
JOURNAL ARTICLE
Prantik Das, Alison Booth, Robert Donaldson, Noami Berfeld, Beth Nordstrom, Robert Carroll, Poonam Dhokia, Andrew Clark, Luis Vaz
BACKGROUND AND OBJECTIVE: Considering the rapidly evolving treatment landscape of renal cell carcinoma (RCC), recent descriptions of the RCC population in the UK are lacking, as are real-world data on treatment and patient outcomes. To analyse the demographic and clinical characteristics, treatment patterns, and overall survival of patients with RCC using national data sets in England. PATIENTS AND METHODS: This was a retrospective cohort study of patients diagnosed with RCC (all stages) between 2014-2018 using demographic, clinical, cancer registration, and treatment data...
March 22, 2024: Clinical Genitourinary Cancer
https://read.qxmd.com/read/38641443/site-specific-differences-of-eligibility-for-adjuvant-immunotherapy-among-urothelial-carcinoma-patients-treated-with-radical-surgery-results-from-a-multicenter-cohort-study
#38
JOURNAL ARTICLE
Chisato Narita, Fumihiko Urabe, Wataru Fukuokaya, Kosuke Iwatani, Yu Imai, Keiji Yasue, Keiichiro Mori, Koichi Aikawa, Takafumi Yanagisawa, Shoji Kimura, Kojiro Tashiro, Shunsuke Tsuzuki, Yuta Yamada, Steffi Kar Kei Yuen, Jeremy Yuen-Chun Teoh, Tatsuya Shimomura, Hiroki Yamada, Akira Furuta, Jun Miki, Takahiro Kimura
BACKGROUND: The CheckMate274 trial has reported enhanced disease-free survival rates in patients with stage pT3-4/ypT2-4 or pN+ urothelial carcinoma (UC) undergoing adjuvant nivolumab therapy. This study compares prognostic differences between urothelial carcinoma of the bladder (UCB) and upper tract urothelial carcinoma (UTUC). METHODS: We retrospectively analyzed data from 719 patients with UC who underwent radical surgery, stratifying to patients at stage pT3-4 and/or pN+ without neoadjuvant chemotherapy (NAC) or at ypT2-4 and/or ypN+ with NAC (potential candidates for adjuvant immunotherapy), and to those who were not candidates for adjuvant immunotherapy...
March 21, 2024: Clinical Genitourinary Cancer
https://read.qxmd.com/read/38638674/liposome-encapsulated-progesterone-efficiently-suppresses-b-lineage-cell-proliferation
#39
JOURNAL ARTICLE
Toshiro Seki, Rikio Suzuki, Shino Ohshima, Yoshiyuki Manabe, Shion Onoue, Yuki Hoshino, Atsushi Yasuda, Ryoji Ito, Hiroshi Kawada, Hitoshi Ishimoto, Takashi Shiina, Yoshie Kametani
Progesterone suppresses several ancient pathways in a concentration-dependent manner. Based on these characteristics, progesterone is considered a candidate anticancer drug. However, the concentration of progesterone used for therapy should be higher than the physiological concentration, which makes it difficult to develop progesterone-based anticancer drugs. We previously developed liposome-encapsulated progesterone (Lipo-P4) with enhanced anticancer effects, which strongly suppressed triple-negative breast cancer cell proliferation in humanized mice...
July 2024: Biochemistry and Biophysics Reports
https://read.qxmd.com/read/38637140/a-systematic-review-on-the-diagnostic-value-of-fibroblast-activation-protein-inhibitor-pet-ct-in-genitourinary-cancers
#40
JOURNAL ARTICLE
Marinus J Hagens, Pim J van Leeuwen, Maurits Wondergem, Thierry N Boellaard, Francesco Sanguedolce, Daniela E Oprea-Lager, Axel Bex, André N Vis, Henk G van der Poel, Laura S Mertens
In contemporary oncologic diagnostics, molecular imaging modalities are pivotal for precise local and metastatic staging. Recent studies identified fibroblast activation protein as a promising target for molecular imaging across various malignancies. Therefore, we aimed to systematically evaluate the current literature on the utility of fibroblast activation protein inhibitor (FAPI) PET/CT for staging patients with genitourinary malignancies. Methods: A systematic Embase and Medline search was conducted, according to the Preferred Reporting Items for Systematic Reviews and Meta-Analyses (PRISMA) process, on August 1, 2023...
April 18, 2024: Journal of Nuclear Medicine
keyword
keyword
12350
2
3
Fetch more papers »
Fetching more papers... Fetching...
Remove bar
Read by QxMD icon Read
×

Save your favorite articles in one place with a free QxMD account.

×

Search Tips

Use Boolean operators: AND/OR

diabetic AND foot
diabetes OR diabetic

Exclude a word using the 'minus' sign

Virchow -triad

Use Parentheses

water AND (cup OR glass)

Add an asterisk (*) at end of a word to include word stems

Neuro* will search for Neurology, Neuroscientist, Neurological, and so on

Use quotes to search for an exact phrase

"primary prevention of cancer"
(heart or cardiac or cardio*) AND arrest -"American Heart Association"

We want to hear from doctors like you!

Take a second to answer a survey question.